Atypical Hemolytic Uremic Syndrome
Is Soliris Effective in aHUS with Complement-Amplifying Conditions?
New Data Shows Soliris Provides Reduction in Post-Transplant Dialysis in aHUS Patients
Alexion Begins 2 Phase 3 trials for 2 Rare Diseases
Do You Want to Be a Rare Disease Superhero?
Spotlight on aHUS
Canada Says No To Alexion's aHUS Orphan Drug
Kidney Week 2015: Long-Term Data with Soliris (eculizumab) is Impressive
Anti-aHUS Bio-therapy Fast-Tracked
Anti-aHUS Bio-therapy Closing in on Marketplace Approval
Brief Overview of Atypical Hemolytic Uremic Syndrome
Does Eculizumab Play a Role in Treating Pregnancy-Associated Atypical Hemolytic-Uremic Syndrome?
Multiple Soliris Trials to Treat aHUS Presented at Nephrology Meeting
Next Page >>
MOST POPULAR ARTICLES
June 19 is World Sickle Cell Day
Ray Comenzo, MD, Discusses ANDROMEDA Trial in AL Amyloidosis Patients
ALS and FTD Novel Small Molecule Therapy Receives Fast Track SBIR Grant
Researchers Prove Rasmussen's Encephalitis Is An Autoimmune Disease
STRATEGIC ALLIANCE PARTNERSHIP PROGRAM >
Familial Chylomicronemia Syndrome
MJH ASSOCIATES >
Specialty Pharmacy Times
Terms & Conditions
Copyright © RareDR 2013-2018 Rare Disease Communications. All Rights Reserved.